Research progress of glucocorticoid resistance in chronic rhinosinusitis with nasal polyps: A review

被引:2
作者
Chen, Langlang [1 ,2 ]
Fan, Xin [1 ]
Yang, Lina [3 ]
Han, Lu [2 ]
Wang, Ningbo [1 ]
Bian, Ka [1 ,4 ]
机构
[1] Air Force Med Univ, Tangdu Hosp, Dept Otolaryngol Head & Neck Surg, Xian, Peoples R China
[2] Yanan Univ, Med Coll, Yanan, Peoples R China
[3] Air Fourth Med Univ, Sch Stomatol, State Key Lab Oral & Maxillofacial Reconstruct & R, Xian, Peoples R China
[4] Air Fourth Med Univ, Tangdu Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710000, Peoples R China
关键词
glucocorticoids; nasal polyps; receptors; resistance; rhinosinusitis; EOSINOPHILIC CHRONIC RHINOSINUSITIS; NF-KAPPA-B; ACUTE LYMPHOBLASTIC-LEUKEMIA; VITAMIN-D DECREASES; CORTICOSTEROID RESISTANCE; GASTROESOPHAGEAL-REFLUX; STEROID-RESISTANT; CHRONIC SINUSITIS; RECEPTOR-ALPHA; AIRWAY INFLAMMATION;
D O I
10.1097/MD.0000000000036024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic rhinosinusitis with nasal polyps (CRSwNP) is one of the common chronic inflammatory diseases in otolaryngology. Glucocorticoid (GC) acts as the first-line drug for the treatment of CRSwNP in clinical practice, and they play an irreplaceable role in reducing nasal mucosal inflammation and restoring the normal physiological function of the nasal mucosa. However, many patients are still insensitive to GC treatment, known as GC resistance, which leads to poor control of the disease, and the underlying mechanisms are still not fully elucidated. This article provides a comprehensive overview of the research progress of GC resistance of patients with CRSwNP in recent years.
引用
收藏
页数:12
相关论文
共 197 条
[1]   Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1 [J].
Abraham, Sonya M. ;
Lawrence, Toby ;
Kleiman, Anna ;
Warden, Paul ;
Medghalchi, Mino ;
Tuckermann, Jan ;
Saklatvala, Jeremy ;
Clark, Andrew R. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (08) :1883-1889
[2]   Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells [J].
Acosta-Rodriguez, Eva V. ;
Rivino, Laura ;
Geginat, Jens ;
Jarrossay, David ;
Gattorno, Marco ;
Lanzavecchia, Antonio ;
Sallusto, Federica ;
Napolitani, Giorgio .
NATURE IMMUNOLOGY, 2007, 8 (06) :639-646
[3]   Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction [J].
Adenuga, David ;
Caito, Samuel ;
Yao, Hongwei ;
Sundar, Isaac K. ;
Hwang, Jae-Woong ;
Chung, Sangwoon ;
Rahman, Irfan .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 403 (3-4) :452-456
[4]   Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed? [J].
Agarwal, Aarti ;
Spath, Derek ;
Sherris, David A. ;
Kita, Hirohito ;
Ponikau, Jens U. .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2020, 59 (02) :141-149
[5]   Prevalence and Risk Factors of Chronic Rhinosinusitus, Allergic Rhinitis, and Nasal Septal Deviation Results of the Korean National Health and Nutrition Survey [J].
Ahn, Jae-Cheul ;
Kim, Jeong-Whun ;
Lee, Chul Hee ;
Rhee, Chae-Seo .
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 142 (02) :162-167
[6]   Cost-effectiveness and comparative effectiveness of biologic therapy for asthma To biologic or not to biologic? [J].
Anderson, William C., III ;
Szefler, Stanley J. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (04) :367-372
[7]   Allergic rhinitis, rhinosinusitis, and asthma: one airway disease [J].
Bachert, C ;
Vignola, AM ;
Gevaert, P ;
Leynaert, B ;
Van Cauwenberge, P ;
Bousquet, J .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (01) :19-+
[8]   Role of staphylococcal superantigens in upper airway disease [J].
Bachert, Claus ;
Zhang, Nan ;
Patou, Joke ;
van Zele, Thibaut ;
Gevaert, Philippe .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 8 (01) :34-38
[9]  
Bachert C, 2020, J ALLER CL IMM-PRACT, V8, P1514, DOI 10.1016/j.jaip.2020.03.007
[10]   Biologics for chronic rhinosinusitis with nasal polyps [J].
Bachert, Claus ;
Zhang, Nan ;
Cavaliere, Carlo ;
Wen Weiping ;
Gevaert, Elien ;
Krysko, Olga .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (03) :725-739